Survival data of animals treated with total A20 RNA-or iLRP RNA-transfected DCs
. | Experimental group . | MST, da . | Survival (%) . |
|---|---|---|---|
| Tumor challenge experiments* | |||
| 1 | Tumor control | 45 | 0/12 (0) |
| 2 | DC | 48 | 0/12 (0) |
| 3 | DC + total A20 RNA | > 140 | 9/12 (75) |
| 4 | DC + iLRP RNA | > 140 | 8/12 (67) |
| Established tumors† | |||
| 1 | Tumor control | 38 | 0/12 (0) |
| 2 | DC | 41 | 0/12 (0) |
| 3 | DC + total A20 RNA | > 140 | 8/12 (67) |
| 4 | DC + iLRP RNA | 62 | 6/12 (50) |
. | Experimental group . | MST, da . | Survival (%) . |
|---|---|---|---|
| Tumor challenge experiments* | |||
| 1 | Tumor control | 45 | 0/12 (0) |
| 2 | DC | 48 | 0/12 (0) |
| 3 | DC + total A20 RNA | > 140 | 9/12 (75) |
| 4 | DC + iLRP RNA | > 140 | 8/12 (67) |
| Established tumors† | |||
| 1 | Tumor control | 38 | 0/12 (0) |
| 2 | DC | 41 | 0/12 (0) |
| 3 | DC + total A20 RNA | > 140 | 8/12 (67) |
| 4 | DC + iLRP RNA | 62 | 6/12 (50) |